The calcium-sensitizing inotrope was of no help weaning patients off venoarterial (VA) extracorporeal membrane oxygenation ...
Reduction in the frequency of hospitalizations, by delaying additional episodes of acute decompensated heart failure; and Weaning patients with severe heart failure who are currently dependent on ...
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products for the critical care ...
Parsippany, NJ - A new intravenous hypertension agent in development has been shown to successfully lower blood pressure in patients undergoing cardiac surgery. Treatment with clevidipine (Clevelox TM ...